Citations

Clear

6273 citation(s) found for "To, Andrew".

Interventional Radiology (RadCases)
Smith, Andrew

Mayo Clinic

American Journal of Roentgenology | January 21, 2011 | Volume: 196 | Issue: 2 | Pages: W223-W223

10.2214/ajr.10.5226 Get It

A biomechanical comparison of the Delta screw and RetroScrew tibial fixation on initial intra‐articular graft tension
Rhee, Peter C. , Levy, Bruce A. , Thoreson, Andrew R. , An, Kai-Nan, Dahm, Diane L., Stuart, Michael J. , An, Kai‐Nan

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | January 21, 2011 | Volume: 19 | Issue: 5 | Pages: 781-786

10.1007/s00167-010-1366-z | PMID 21258782 Get It

AbstractPurposeThe purpose of this study is to determine the effect of bioabsorbable interference screw (BIS) tibial fixation with the Delta screw (antegrade) and RetroScrew (retrograde) on initial (time zero) intra‐articular graft tension in soft tissue anterior cruciate ligament (ACL) reconstruction in a cadaveric model.MethodsTen matched pairs of cadaveric tibias received one of two tibial fixation constructs using quadrupled hamstring grafts, Delta screw (antegrade) or the RetroScrew (retrograde). Each specimen was mounted to the materials testing device with the displacement force vector in line with the tibial tunnel. The construct was pre‐tensioned (10–30 N, 0.1 Hz, 10 cycles), a baseline tension of 25 N was introduced, and the change in intra‐articular graft tension before and after screw insertion was recorded.ResultsSegmental (proximal, middle, distal) BMD was utilized to assess BMD using quantitative computed tomography (qCT). The Delta screw had a higher maximum insertion torque (P = 0.03) and exhibited a larger increase in intra‐articular graft tension as compared to the RetroScrew (38.3 ± 17.9 N, 7.6 N ± 14.4, P = 0.004), respectively. There were no significant correlations between intra‐articular graft tension increase to maximum insertion torque (P = NS) or corresponding segmental BMD (P = NS).ConclusionsDelta screw tibial fixation (antegrade) in soft tissue ACL reconstruction significantly increases the initial intra‐articular graft tension as compared to RetroScrew screw fixation (retrograde) in this cadaveric model. Delta screw (antegrade) tibial fixation may increase initial quadrupled hamstring graft intra‐articular tension with currently accepted insertion techniques.
Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure
Maisel, William H., Friedman, Paul A. , Kallinen, Linda M., Mugglin, Andrew S. , Kumar, Kapil , Hodge, David O. , Morrison, Thomas B., Hayes, David L. , Hauser, Robert G.

Mayo Clinic

Circulation | January 18, 2011 | Volume: 123 | Issue: 4 | Pages: 358-363

10.1161/circulationaha.110.975219 | PMID 21242478 Get It

Background— Sprint Fidelis (Fidelis) implantable cardioverter-defibrillator leads are prone to fractures that have caused adverse events, primarily inappropriate shocks, and a few reported deaths. More than 100 000 patients have Fidelis leads. No independent multicenter long-term performance information exists for this lead, and single-center studies suggest that certain patients are at increased risk for Fidelis failure. Our aim was to assess the longevity of Fidelis leads and to evaluate clinical variables and adverse events associated with Fidelis failure. The results were compared with like data for Quattro Secure (Quattro) implantable cardioverter-defibrillator leads implanted at our centers. Methods and Results— This 3-center study included adults ≥18 years of age who received Fidelis or Quattro leads for the prevention of sudden cardiac death. From November 2001 to January 2009,1023 Fidelis and 1668 Quattro leads were implanted and followed up. The failure rate for Fidelis leads was 2.81%/y compared with 0.43%/y for Quattro leads ( P <0.0001). No deaths or injuries occurred as a result of lead failure, but 42% of fractures caused inappropriate shocks. The survival of Fidelis leads at 4 years was 87.0% (95% confidence interval, 83.6 to 90.1) compared with 98.7% (95% confidence interval, 97.9 to 99.4) for Quattro leads ( P <0.0001). Multivariate predictors of Fidelis failure were younger age (hazard ratio, 0.98; 95% confidence interval, 0.96 to 0.99), female gender (hazard ratio, 0.61; 95% confidence interval, 0.40 to 1.00), and cardiac disease ( P =0.041). Conclusions— Compared with Quattro leads, the survival of Fidelis leads continues to decline, and Fidelis failure is notably higher in younger patients, women, individuals with hypertrophic cardiomyopathy, and patients with arrhythmogenic right ventricular dysplasia or channelopathies. These findings have significant implications for the management of patients who have Fidelis leads, and they demonstrate the importance of weighing clinical variables in assessments of implantable cardioverter-defibrillator lead performance.
Pearls & Oy-sters: Clues for spinal dural arteriovenous fistulae
McKeon, Andrew , Lindell, E. Paul , Atkinson, J.L.D. , Weinshenker, Brian G. , Piepgras, D. G., Pittock, Sean J. , Pittock, S J , Weinshenker, Brian G , McKeon, Andrew

Mayo Clinic

Neurology | January 17, 2011 | Volume: 76 | Issue: 3 | Pages: No page available

10.1212/wnl.0b013e3182074a42 | PMID 21242488 Get It

Regression of Serous Macular Detachment Due to Peripheral Exudative Hemorrhagic Chorioretinopathy following Intravitreal Bevacizumab
Kadikoy, Hüseyin, Holz, Eric R. , Carvounis, Petros , Barkmeier, Andrew J.

Mayo Clinic

European Journal of Ophthalmology | January 14, 2011 | Volume: 21 | Issue: 4 | Pages: 506-508

10.5301/ejo.2011.6246 | PMID 21240857 Get It

Purpose TO describe a case of exudative macular detachment secondary to peripheral exudative chorioretinopathy with a favorable anatomic and visual outcome following treatment with intravitreal bevacizumab. Methods The medical records of a patient with peripheral exudative chorioretinopathy were reviewed. Results Macular reattachment was achieved with a corresponding visual acuity improvement that was maintained over an uncomplicated 17-month clinical course. Conclusions Bevacizumab may be an effective treatment option for exudative macular detachment secondary to peripheral exudative hemorrhagic chorioretinopathy.
Quality Control Procedures for Genome‐Wide Association Studies
Turner, Stephen , Armstrong, Loren L., Bradford, Yuki, Carlson, Christopher S. , Crawford, Dana C. , Crenshaw, Andrew, Doheny, Kimberly F. , Haines, Jonathan L. , Hayes, Geoffrey, Jarvik, Gail P. , Jiang, Lan , Li, Rongling, Manolio, Teri A. , Matsumoto, Martha, McCarty, Catherine A. , McDavid, Andrew , Mirel, Daniel B., Paschall, Justin, Pugh, Elizabeth, Rasmussen, Luke V. , Wilke, Russell A. , Zuvich, Rebecca L., Ritchie, Marylyn D. , Andrade, Mariza de , Kullo, Iftikhar J. , Ling, Hua , Jarvik, Gail P , Rasmussen, Luke V

Mayo Clinic

Current Protocols in Human Genetics | January 13, 2011 | Volume: 68 | Issue: 1 | Pages: No page available

10.1002/0471142905.hg0119s68 | PMID 21234875 Get It

AbstractGenome‐wide association studies (GWAS) are being conducted at an unprecedented rate in population‐based cohorts and have increased our understanding of the pathophysiology of complex disease. Regardless of context, the practical utility of this information will ultimately depend upon the quality of the original data. Quality control (QC) procedures for GWAS are computationally intensive, operationally challenging, and constantly evolving. Here we enumerate some of the challenges in QC of GWAS data and describe the approaches that the electronic MEdical Records and Genomics (eMERGE) network is using for quality assurance in GWAS data, thereby minimizing potential bias and error in GWAS results. We discuss common issues associated with QC of GWAS data, including data file formats, software packages for data manipulation and analysis, sex chromosome anomalies, sample identity, sample relatedness, population substructure, batch effects, and marker quality. We propose best practices and discuss areas of ongoing and future research. Curr. Protoc. Hum. Genet. 68:1.19.1‐1.19.18 © 2011 by John Wiley & Sons, Inc.
Junctophilin-2 Expression Silencing Causes Cardiocyte Hypertrophy and Abnormal Intracellular Calcium-Handling
Landstrom, Andrew P. , Kellen, Cherisse A., Dixit, Sayali S., Oort, Ralph J. van, Garbino, Alejandro , Weisleder, Noah , Ma, Jianjie, Wehrens, Xander H.T. , Ackerman, Michael J. , Landstrom, Andrew P , Wehrens, Xander H T

Mayo Clinic

Circulation: Heart Failure | January 8, 2011 | Volume: 4 | Issue: 2 | Pages: 214-223

10.1161/circheartfailure.110.958694 | PMID 21216834 Get It

Background— Junctophilin-2 (JPH2), a protein expressed in the junctional membrane complex, is necessary for proper intracellular calcium (Ca 2+ ) signaling in cardiac myocytes. Downregulation of JPH2 expression in a model of cardiac hypertrophy was recently associated with defective coupling between plasmalemmal L-type Ca 2+ channels and sarcoplasmic reticular ryanodine receptors. However, it remains unclear whether JPH2 expression is altered in patients with hypertrophic cardiomyopathy (HCM). In addition, the effects of downregulation of JPH2 expression on intracellular Ca 2+ handling are presently poorly understood. We sought to determine whether loss of JPH2 expression is noted among patients with HCM and whether expression silencing might perturb Ca 2+ handling in a prohypertrophic manner. Methods and Results— JPH2 expression was reduced in flash-frozen human cardiac tissue procured from patients with HCM compared with ostensibly healthy traumatic death victims. Partial silencing of JPH2 expression in HL-1 cells by a small interfering RNA probe targeted to murine JPH2 mRNA (shJPH2) resulted in myocyte hypertrophy and increased expression of known markers of cardiac hypertrophy. Whereas expression levels of major Ca 2+ -handling proteins were unchanged, shJPH2 cells demonstrated depressed maximal Ca 2+ transient amplitudes that were insensitive to L-type Ca 2+ channel activation with JPH2 knockdown. Further, reduced caffeine-triggered sarcoplasmic reticulum store Ca 2+ levels were observed with potentially increased total Ca 2+ stores. Spontaneous Ca 2+ oscillations were elicited at a higher extracellular [Ca 2+ ] and with decreased frequency in JPH2 knockdown cells. Conclusions— Our results show that JPH2 levels are reduced in patients with HCM. Reduced JPH2 expression results in reduced excitation-contraction coupling gain as well as altered Ca 2+ homeostasis, which may be associated with prohypertrophic remodeling.
The Birth of Neurohospitalists
Josephson, S. Andrew , Freeman, William D.

Mayo Clinic

The Neurohospitalist | January 6, 2011 | Volume: 1 | Issue: 1 | Pages: 5-7

10.1177/1941875210385250 | PMID 23983831 Get It

Sustained Delivery of Dibutyryl Cyclic Adenosine Monophosphate to the Transected Spinal Cord Via Oligo [(Polyethylene Glycol) Fumarate] Hydrogels
Rooney, Gemma E., Madigan, Nicolas N. , Gross, LouAnn, Chen, BingKun, Vallejo‐Giraldo, Catalina , Seo, Seungmae , Nesbitt, Jarred J., Dadsetan, Mahrokh, Yaszemski, Michael J. , Windebank, Anthony J. , Knight, Andrew Michael

Mayo Clinic

Tissue Engineering Part A | January 4, 2011 | Volume: 17 | Issue: 9-10 | Pages: 1287-1302

10.1089/ten.tea.2010.0396 | PMID 21198413 Get It